Drug Approval | March 19, 2025
Briefs: Zydus, Alkem Laboratories, Alkem Medtech and Relonchem
Alkem Medtech to acquire 100% stake of Bombay Ortho
Alkem Medtech to acquire 100% stake of Bombay Ortho
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
This innovative formulation combines cutting-edge ingredients is a first of its kind in India to have a Duo-Lipo technology
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India with support from Sonnet and enable global and India regulatory filings
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
The company disclosed that several employees of a subsidiary had their business email addresses stolen
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
The company has received Form 483 with three observations
Subscribe To Our Newsletter & Stay Updated
